Animal hepacivirus models for hepatitis C virus immune responses and pathology

Matthew J. Kennedy,Sonja Fernbach,Troels K.H. Scheel
DOI: https://doi.org/10.1016/j.jhep.2023.12.019
IF: 25.7
2024-04-26
Journal of Hepatology
Abstract:Chronic HCV infection is a leading cause of cirrhosis and hepatocellular carcinoma. While curable with antiviral therapy, a vaccine is essential for HCV containment and eradication. Vaccine development ideally requires immunocompetent animal models, and in vitro systems for assessment of neutralising antibodies (nAbs). Engineered mouse models supporting HCV infection and replication are available but have blunted immune responses, limiting their suitability for vaccine studies. HCV incurred
gastroenterology & hepatology
What problem does this paper attempt to address?